129 related articles for article (PubMed ID: 9134833)
21. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
[TBL] [Abstract][Full Text] [Related]
22. Minimal change nephrotic syndrome in children: deaths during the first 5 to 15 years' observation. Report of the International Study of Kidney Disease in Children.
Pediatrics; 1984 Apr; 73(4):497-501. PubMed ID: 6709428
[TBL] [Abstract][Full Text] [Related]
23. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
[TBL] [Abstract][Full Text] [Related]
24. Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults.
Takei T; Itabashi M; Moriyama T; Kojima C; Shiohira S; Shimizu A; Tsuruta Y; Ochi A; Amemiya N; Mochizuki T; Uchida K; Tsuchiya K; Nitta K
Nephrol Dial Transplant; 2013 May; 28(5):1225-32. PubMed ID: 23239834
[TBL] [Abstract][Full Text] [Related]
25. Low serum immunoglobulin G--a predictor of frequent relapses in idiopathic nephrotic syndrome.
Andal A; Chellani H; Anand NK; Chandra M
Indian Pediatr; 1990 Oct; 27(10):1045-9. PubMed ID: 2090591
[TBL] [Abstract][Full Text] [Related]
26. [Longitudinal study in children with the nephrotic syndrome and minimal glomerular lesion].
Martini RJ; Gomila A; Solanas G
Bol Med Hosp Infant Mex; 1977; 34(5):1105-16. PubMed ID: 758027
[TBL] [Abstract][Full Text] [Related]
27. Systemic lupus erythematosus in a patient with remitting minimal change nephrotic syndrome.
Nishihara G; Nakamoto M; Yasunaga C; Takeda K; Matsuo K; Urabe M; Goya T; Sakemi T
Clin Nephrol; 1997 Nov; 48(5):327-30. PubMed ID: 9403219
[TBL] [Abstract][Full Text] [Related]
28. Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome.
Eguchi A; Takei T; Yoshida T; Tsuchiya K; Nitta K
Nephrol Dial Transplant; 2010 Jan; 25(1):124-9. PubMed ID: 19740915
[TBL] [Abstract][Full Text] [Related]
29. Minimal change nephrotic syndrome.
Almeida AF; Chafekar DS
J Assoc Physicians India; 1993 May; 41(5):257-8. PubMed ID: 8300452
[No Abstract] [Full Text] [Related]
30. Management strategy for idiopathic nehprotic syndrome in children.
Chiu MC
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):1-7. PubMed ID: 18245896
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic correlation of C1q nephropathy in children.
Fukuma Y; Hisano S; Segawa Y; Niimi K; Tsuru N; Kaku Y; Hatae K; Kiyoshi Y; Mitsudome A; Iwasaki H
Am J Kidney Dis; 2006 Mar; 47(3):412-8. PubMed ID: 16490619
[TBL] [Abstract][Full Text] [Related]
32. [Lipoid nephrosis in childhood].
Niaudet P
Rev Prat; 2003 Nov; 53(18):2027-32. PubMed ID: 15008217
[TBL] [Abstract][Full Text] [Related]
33. Long-term effects of steroid treatment on nephrotic syndrome associated with Kimura's disease and a review of the literature.
Matsuda O; Makiguchi K; Ishibashi K; Chida Y; Ida T; Matsuda K; Tomita K; Marumo F; Hiruma M
Clin Nephrol; 1992 Mar; 37(3):119-23. PubMed ID: 1563115
[TBL] [Abstract][Full Text] [Related]
34. The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome.
Dinçel N; Yılmaz E; Kaplan Bulut İ; Hacıkara Ş; Mir S
Ren Fail; 2015; 37(8):1267-72. PubMed ID: 26313331
[TBL] [Abstract][Full Text] [Related]
35. Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations.
François H; Daugas E; Bensman A; Ronco P
Am J Kidney Dis; 2007 Jan; 49(1):158-61. PubMed ID: 17185157
[TBL] [Abstract][Full Text] [Related]
36. Aggravation of minimal change nephrotic syndrome by administration of human albumin.
Yoshimura A; Ideura T; Iwasaki S; Taira T; Koshikawa S
Clin Nephrol; 1992 Mar; 37(3):109-14. PubMed ID: 1563113
[TBL] [Abstract][Full Text] [Related]
37. Stability of remission in minimal lesion nephrotic syndrome after treatment with prednisolone and cyclophosphamide.
Dundon S; O'Callaghan U; Raftery J
Int J Pediatr Nephrol; 1980 Mar; 1(1):22-5. PubMed ID: 7343524
[No Abstract] [Full Text] [Related]
38. The many faces of minimal change nephrotic syndrome: an overview and case study.
Richardson MA
Nephrol Nurs J; 2012; 39(5):365-74; quiz 375. PubMed ID: 23094339
[TBL] [Abstract][Full Text] [Related]
39. Hypothalamic-pituitary-adrenal (HPA) function in adrenocortical steroid treated minimal change nephrotic syndrome.
Moel DI; Kwun YA; Teitcher J
Clin Nephrol; 1980 Jul; 14(1):36-41. PubMed ID: 6250751
[TBL] [Abstract][Full Text] [Related]
40. Behavioural abnormalities in children with nephrotic syndrome.
Mishra OP; Basu B; Upadhyay SK; Prasad R; Schaefer F
Nephrol Dial Transplant; 2010 Aug; 25(8):2537-41. PubMed ID: 20200003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
